CrushSCI.com
提供学术论文选刊润色服务
AMERICAN JOURNAL OF HEMATOLOGY 期刊封面 医学
返回期刊列表

Review Cycle Records

AMERICAN JOURNAL OF HEMATOLOGY

Wiley SCIE 非OA
2026新锐 1区2025中科院 1区 TOP2025 JCR Q1
62.0平均天数
49中位天数
3最短天数
236最长天数
3842025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

33 天

p53 Immunohistochemistry Is a Reliable Method for Assessing TP53 Allelic and Functional Status in TP53 ‐Mutated Cases

作者Hong Fang; Joseph D. Khoury; Zhenya Tang; Sa A. Wang; Courtney D. DiNardo; Sanam Loghavi; Wei J. Wang; Yiannis Petros Dimopoulos; Shimin Hu; C. Cameron Yin; Siba El Hussein; Hui Zhang; Jayastu Senapati; Kelly Chien; Michael Andreeff; L. Jeffrey Medeiros; Wei Wang

作者单位1. Department of Hematopathology University of Texas MD Anderson Cancer Center Houston Texas USA; 2. Department of Pathology, Microbiology and Immunology University of Nebraska Medical Center Omaha Nebraska USA; 3. Department of Leukemia University of Texas MD Anderson Cancer Center Houston Texas USA; 4. Department of Pathology University of Vermont Larner College of Medicine Burlington Vermont USA

PDF源文件 DOI 网页
63 天

EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion‐Dependent Thalassemia

作者Anthony Iscaro; Simona Leoni; Filippo Russo; Valentina Brancaleoni; Barbara Eleni Rosato; Roberta Marra; Antonella Nostroso; Natalia Scaramellini; Daniele Lello Panzieri; Iris Villa; Teresa Ceglie; Carmen Maria Gaglioti; Neha Kargutkar; Vito Alessandro Lasorsa; Mario Capasso; Giovanni Battista Ferrero; Immacolata Andolfo; Irene Motta; Roberta Russo

作者单位1. Dipartimento di Medicina Molecolare e Biotecnologie Mediche Università degli Studi di Napoli Federico II Naples Italy; 2. CEINGE Biotecnologie Avanzate Franco Salvatore Naples Italy; 3. Dipartimento di Scienze Cliniche e di Comunità, Dipartimento di Eccellenza 2023–2027 University of Milan Milan Italy; 4. SC Medicina ad Indirizzo Metabolico, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy; 5. University of Milan Milan Italy; 6. Department of Clinical and Biological Sciences University of Turin Turin Italy

PDF源文件 DOI 网页
3 天

Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk‐Stratification and Management

作者Guillermo Garcia‐Manero

作者单位1. Department of Leukemia University of Texas MD Anderson Cancer Center Houston Texas USA

PDF源文件 DOI 网页
9 天

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children

作者Sigrid van der Veen; Bart J. Biemond; Marjon H. Cnossen; Pablo Bartolucci; Maria P. Boaro; Betzabel Cajiao Garcia; Raffaella Colombatti; M. D'Agnolo; Karin Fijnvandraat; Anna Collado Gimbert; Amira Idrizovic; Petros Kountouris; Mar Mañú‐Pereira; Elisabetta Mezzalira; Mariane de Montalembert; Erfan Nur; A. Pham Hung D' Alexandry D'Orengiani; Tiziana Sanavia; Saskia E. M. Schols; Marissa J. M. Traets; Minke A. E. Rab; Sara I. Reidel; Anita W. Rijneveld; Yosr Zaouali; Nanda M. Verhoeven‐Duif; Judith J. M. Jans; Eduard J. van Beers

作者单位1. Center for Benign Hematology, Thrombosis and Hemostasis – Van Creveldkliniek, University Medical Center Utrecht, Utrecht University Utrecht the Netherlands; 2. Section Metabolic Diagnostics, Department of Genetics University Medical Centre Utrecht, Utrecht University Utrecht the Netherlands; 3. Department of Hematology Amsterdam University Medical Center Amsterdam the Netherlands; 4. Department of Pediatric Hematology and Oncology, Erasmus MC ‐ Sophia Children's Hospital Erasmus University Medical Center Rotterdam Rotterdam the Netherlands; 5. University Paris‐Est‐Créteil, IMRB, Inserm U955, Henri Mondor University Hospitals, APHP, Sickle Cell Referral Center‐UMGGR Creteil France; 6. UOC Oncoematologia Pediatrica, Azienda Ospedale‐Università Padova Padua Italy; 7. Department of Women's and Children's Health University of Padua Padua Italy; 8. Department of Pediatric Hematology Amsterdam UMC, Emma Children's Hospital Amsterdam the Netherlands; 9. Sanquin Research, Department of Molecular Cellular Hemostasis Amsterdam the Netherlands; 10. Rare Anemia Research Laboratory, Vall D'hebron Institut de Recerca Barcelona Spain; 11. Pediatric Oncology and Hematology Department Hospital Universitari Vall D'hebron Barcelona Spain; 12. Genetics and Microbiology Department Universitat Autonoma de Barcelona Barcelona Spain; 13. Molecular Genetics Thalassaemia Department The Cyprus Institute of Neurology and Genetics Nicosia Cyprus; 14. Department of General Pediatrics and Pediatric Infectious Diseases Sickle Cell Center, Necker‐Enfants Malades Hospital Neuilly France; 15. Department of Blood Cell Research Sanquin Research and Landsteiner Laboratory Amsterdam the Netherlands; 16. AI and Computational Biomedicine Unit, Department of Medical Sciences University of Torino Turin Italy; 17. Department of Hematology Radboud University Medical Center Nijmegen the Netherlands; 18. Central Diagnostic Laboratory ‐ Research, University Medical Center Utrecht Utrecht the Netherlands; 19. Department of Hematology Erasmus University Medical Center Rotterdam the Netherlands

PDF源文件 DOI 网页
67 天

High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1%

作者Orianne Wagner‐Ballon; Anne‐Catherine Lhoumeau; Anna Raimbault; Camille Debord; Jean‐Philippe Vial; Valérie Soenen; Mélanie Pannetier; Edouard Bonneville; Elsa Bera; Caroline Bret; Nicolas Chapuis; Véronique Latger‐Cannard; Caroline Mayeur‐Rousse; Véronique Harrivel; François Vergez; Marie Loosveld; Juliette Vo Xuan; Stéphanie Mathis; Gérard Socié; Flore Sicre de Fontbrune; Régis Peffault de Latour; Bernard Drenou; Agathe Debliquis; Magali Le Garff‐Tavernier; the French PNH working group CytHem‐HPN

作者单位1. Département Hématologie et Immunologie Biologiques APHP Hôpitaux Universitaires Henri Mondor Créteil France; 2. Université Paris‐Est Créteil (UPEC), Inserm U955 IMRB Créteil France; 3. Institut Paoli Calmettes, Laboratoire de Biopathologie Marseille France; 4. APHP Hôpital Saint Louis, Service Hématologie Biologique Paris France; 5. CHU Nantes, Laboratoire Hématologie Nantes France; 6. CHU Bordeaux, Laboratoire Hématologie Bordeaux France; 7. CHU Lille, Laboratoire Hématologie Lille France; 8. CHU de Rennes, Laboratoire Hématologie Rennes France; 9. CHU Grenoble, Laboratoire Hématologie Grenoble France; 10. CHU Rouen, Laboratoire Hématologie Rouen France; 11. CHU Montpellier, Laboratoire Hématologie Montpellier France; 12. APHP CHU Cochin, Laboratoire Hématologie Paris France; 13. CHU Nancy, Laboratoire Hématologie Nancy France; 14. CHU Strasbourg, Laboratoire Hématologie Strasbourg France; 15. CHU Amiens, Laboratoire Hématologie Amiens France; 16. CHU Toulouse, Laboratoire Hématologie Toulouse France; 17. CHU Timone, Laboratoire Hématologie Marseille France; 18. APHP Hôpital Saint Louis, Service Hématologie Clinique Paris France; 19. Groupe Hospitalier de la Région Mulhouse Sud Alsace Service Hématologie Clinique Mulhouse France; 20. Groupe Hospitalier de la Région Mulhouse Sud Alsace Laboratoire Hématologie Mulhouse France; 21. APHP Groupe Hospitalier Pitié‐Salpêtrière‐Charles Foix, Sorbonne Université Service D'hématologie Biologique Paris France; 22. Centre de Recherche Des Cordeliers, Sorbonne Université, Université Paris Cité, Inserm UMRS 1138 Drug Resistance in Hematological Malignancies Team Paris France

PDF源文件 DOI 网页
61 天

Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN / HMA

作者Fieke W. Hoff; Joshua F. Zeidner; Geeta Torlapati; Deedra Nicolet; Krzysztof Mrózek; Ying Huang; Alexander Li; Rina Li Welkie; Ronan T. Swords; Elie Traer; Eytan M. Stein; Tara L. Lin; Maria R. Baer; Vu H. Duong; William G. Blum; Martha L. Arellano; Wendy Stock; Olatoyosi Odenike; Rebecca L. Olin; Catherine C. Smith; Gary J. Schiller; Emily K. Curran; Onyee Chan; Christine McMahon; Michael Hochman; Kieran Sahasrabudhe; Charles Foucar; Jesus Gonzalez‐Lugo; Brittany Knick Ragon; Shivani V. Handa; Nyla A. Heerema; Timothy Chen; Molly Martycz; Mona Stefanos; Sonja G. Marcus; Leonard Rosenberg; Brian J. Druker; Ross L. Levine; Amy Burd; Ashley O. Yocum; Uma M. Borate; Alice S. Mims; Ann‐Katrin Eisfeld; John C. Byrd; Yazan F. Madanat

作者单位1. National Heart, Lung, and Blood Institute National Institutes of Health Bethesda Maryland USA; 2. Division of Hematology, Department of Medicine, Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill North Carolina USA; 3. The James Cancer Hospital The Ohio State University Columbus Ohio USA; 4. Clara D. Bloomfield Center for Leukemia Outcomes Research The Ohio State University Comprehensive Cancer Center Columbus Ohio USA; 5. Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA; 6. Division of Hematology and Medical Oncology, Knight Cancer Institute Oregon Health & Science University Portland Oregon USA; 7. Leukemia Service, Department of Medicine, Human Oncology and Pathogenesis Program Memorial Sloan Kettering Cancer Center New York New York USA; 8. Division of Hematologic Malignancies University of Kansas Medical Center Kansas City Kansas USA; 9. Department of Medicine University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland USA; 10. Department of Hematology and Medical Oncology Winship Cancer Institute of Emory University Atlanta Georgia USA; 11. Section of Hematology/Oncology University of Chicago Chicago Illinois USA; 12. Division of Hematology and Oncology University of California, San Francisco San Francisco California USA; 13. Department of Medicine, Hematology/Oncology David Geffen School of Medicine at University of California, Los Angeles Los Angeles California USA; 14. Division of Hematology & Oncology University of Cincinnati Cincinnati Ohio USA; 15. Malignant Hematology Department H. Lee Moffitt Cancer Center Tampa Florida USA; 16. Division of Hematology, Department of Medicine University of Colorado School of Medicine Aurora Colorado USA; 17. Division of Hematology University of Wisconsin, Carbone Cancer Center Madison Wisconsin USA; 18. Department of Internal Medicine, Division of Hematology and Oncology University of New Mexico Albuquerque New Mexico USA; 19. Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine Charlotte North Carolina USA; 20. Blood Cancer United Washington DC USA; 21. UPMC Hillman Cancer Center University of Pittsburgh Pittsburgh Pennsylvania USA

PDF源文件 DOI 网页
83 天

Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial

作者Santosh Kumar Singh; Rahil Arora; Suman Kumar Pramanik; Abhishek Kumar; Alok Singh; Shantanu Khanna; Nitya Malhotra; Pranay Juneja; Netri Upadhyay; Uday Yanamandra

作者单位1. Department of Internal Medicine Armed Forces Medical College (AFMC) Pune India; 2. Department of Medical Research Armed Forces Medical College (AFMC) Pune India; 3. Department of Medicine Military Hospital Kirkee Pune India; 4. Department of Radiology Command Hospital, Air Force Bangalore India; 5. Department of Medicine, Government Medical College and Hospital Chandigarh India; 6. Department of Medicine, JNMC, DMIHER Wardha India

PDF源文件 DOI 网页
30 天

Clinical Predictors of Response in Chronic Graft‐Versus‐Host Disease: Results From the “Predicting the Quality of Response to Specific Treatments ( PQRST )” Trial

作者Betty K. Hamilton; Lynn Onstad; Paul A. Carpenter; Joseph Pidala; George Chen; Corey Cutler; Najla El Jurdi; Nosha Farhadfar; Mark Juckett; Carrie L. Kitko; Catherine J. Lee; Stephanie J. Lee

作者单位1. Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology Taussig Cancer Institute, Cleveland Clinic Cleveland Ohio USA; 2. Clinical Research Division Fred Hutchinson Cancer Center Seattle Washington USA; 3. H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA; 4. University of Texas MD Anderson Cancer Center Houston Texas USA; 5. Dana Farber Cancer Institute Boston Massachusetts USA; 6. National Cancer Institute, National Institutes of Health Bethesda Maryland USA; 7. Sarah Cannon Transplant and Cellular Program, Methodist Hospital San Antonio Texas USA; 8. University of Minnesota Minneapolis Minnesota USA; 9. Vanderbilt University Medical Center Nashville Tennessee USA

PDF源文件 DOI 网页
236 天

Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B‐ ALL

作者Binjun Xiong; Jianwen Zhou; Xuhan Zhang; Yance Feng; Jie Cheng; Hui Shi; Qian Li; Wenli Tang; Yali Shen; Fen Zhou; Shaoyan Hu; Hua You

作者单位1. Precision Oncology and Intelligent Theranostics Laboratory Children's Hospital of Chongqing Medical University Chongqing China; 2. Ministry of Education Key Laboratory of Child Development and Disorders National Clinical Research Center for Children and Adolescents' Health and Diseases Chongqing China; 3. Department of Hematology and Oncology Children's Hospital Affiliated to Zhengzhou University (Zhengzhou Children's Hospital) Zhengzhou China; 4. Division of Life Sciences and Medicine, Department of Pediatric Hematology and Oncology The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), University of Science and Technology of China Hefei China; 5. Department of Hematology and Oncology Anhui Provincial Children's Hospital Hefei China; 6. Department of Pediatric Hematology and Oncology Children's Hospital of Chongqing Medical University Chongqing China; 7. Department of Pediatrics Union Hospital, Tongji Medical College of Huazhong University of Science and Technology Wuhan China; 8. Department of Hematology and Oncology Children's Hospital of Soochow University Suzhou China; 9. Department of Pediatric Oncology Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China Chengdu China

PDF源文件 DOI 网页
54 天

Quizartinib in Combination With FLAG ‐ IDA for Relapsed or Refractory Acute Myeloid Leukemia ( FLAG ‐ QUIDA ): A PETHEMA Phase I‐ II Trial

作者Teresa Bernal; Javier Zambrano Márquez; Rebeca Rodríguez‐Veiga; Eduardo Rodríguez‐Arbolí; Juan Manuel Bergua‐Burgués; Susana Vives; Montserrat Arnán; Pilar Martínez Sánchez; Pilar Herrera‐Puente; Josefina Serrano‐López; Vicente Rubio; Inmaculada Marchante‐Cepillo; Marta Cervera‐Calvo; Andrés Novo García; Rosa Fernández Martín; Cristina Gil Cortés; Carlos Rodríguez‐Medina; Victor Noriega‐Concepción; Ana Alfonso‐Piérola; Carmen Loredo; María Antuña‐Casal; Blanca Boluda; Isabel Cano‐Ferri; Evelyn Acuña‐Cruz; Laura Torres‐Miñana; Joaquín Sánchez‐García; Cristina Bilbao; Maria Teresa Gómez‐Casares; David Martínez Cuadrón; Pau Montesinos

作者单位1. Servicio de Hematología Hospital Universitario Central de Asturias Oviedo Spain; 2. Instituto de Investigación Sanitaria del Principado de Asturias Oviedo Spain; 3. Instituto Universitario de Oncología del Principado de Asturias Oviedo Spain; 4. Servicio de Hematología Hospital Universitario San Agustín de Avilés Avilés Spain; 5. Servicio de Hematología Hospital U. La Fe Valencia Spain; 6. Servicio de Hematología Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Universidad de Sevilla Sevilla Spain; 7. Servicio de Hematología Hospital San Pedro de Alcántara Cáceres Spain; 8. Servicio de Hematología, ICO Badalona‐Hospital Universitari Germans Trias i Pujol, Institut de Recerca Josep Carreras Badalona Spain; 9. Servicio de Hematología, Institut Catalá D'oncologia Hospitalet del Llobregat Barcelona Spain; 10. Servicio de Hematología Hospital U. 12 de Octubre Madrid Spain; 11. Servicio de Hematología Hospital Ramón y Cajal Madrid Spain; 12. Servicio de Hematología Hospital Reina Sofía, Córdoba, IMIBIC, UCO Córdoba Spain; 13. Servicio de Hematología Hospital Jerez de la Frontera Jerez de la Frontera Spain; 14. Servicio de Hematología Hospital Juan XXIII Tarragona Spain; 15. Servicio de Hematología Hospital Son Espasses Palma de Mallorca Spain; 16. Servicio de Hematología Hospital Insular Materno‐Infantil Las Palmas de Gran Canaria Spain; 17. Servicio de Hematología Hospital General de Alicante Alicante Spain; 18. Servicio de Hematología Hospital Negrín Las Palmas de Gran Canaria Spain; 19. Servicio de Hematología Hospital Complejo Universitario A Coruña Spain; 20. Servicio de Hematología Clínica Universitaria de Navarra Pamplona Spain; 21. Unidad de Investigación y Docencia Hospital Universitario Central de Asturias Oviedo Spain; 22. Departamento de Medicina Universitat de València Valencia Spain

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。